Omega Therapeutics, Inc. (OMGA)

Omega Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	45.85	68.44	70.62	186.48	22.95	2.27
Short-Term Investments	-	4.99	54.06	38.85	-	-
Cash & Short-Term Investments	45.85	73.43	124.68	225.33	22.95	2.27
Cash Growth	-59.42%	-41.11%	-44.67%	881.77%	909.28%	-
Accounts Receivable	0.69	6.13	0.62	0.26	-	-
Other Receivables	0.06	0.86	1.18	0.26	0.19	0.01
Receivables	0.75	6.99	1.8	0.52	0.19	0.01
Prepaid Expenses	8.35	9.17	10.96	3.3	0.78	0.28
Other Current Assets	0.77	0.3	0.16	0.14	0.08	0.1
Total Current Assets	56.06	89.88	137.59	229.29	24	2.65
Property, Plant & Equipment	112.11	114.05	7.86	3.61	3.48	2.83
Other Long-Term Assets	0.05	0.44	0.55	0.44	0.6	0.63
Total Assets	168.23	204.37	146	233.33	28.08	6.12
Accounts Payable	1.72	1.62	3.11	2.11	1.06	0.92
Accrued Expenses	3.94	8.21	13.96	9.58	3.47	1.15
Current Portion of Long-Term Debt	4	4	3.33	-	3	-
Current Portion of Leases	11.83	11.3	1.52	-	-	-
Other Current Liabilities	4.06	1.67	0.04	0.29	0.17	0.17
Total Current Liabilities	25.54	26.81	21.96	11.98	7.7	2.23
Long-Term Debt	12.91	14.89	16.6	19.87	8.73	11.89
Long-Term Leases	98.21	98.24	1.12	-	-	-
Other Long-Term Liabilities	5.3	6.42	0.34	0.85	1.06	1.21
Total Liabilities	141.96	146.35	40.03	32.71	17.49	15.33
Common Stock	0.06	0.06	0.05	0.05	0.01	0.02
Additional Paid-In Capital	397.28	392.61	343.61	335.15	1.59	0.84
Retained Earnings	-371.07	-334.63	-237.21	-134.51	-66.23	-36.78
Comprehensive Income & Other	-	-0.01	-0.48	-0.06	-	-
Total Common Equity	26.26	58.02	105.97	200.63	-64.63	-35.92
Shareholders' Equity	26.26	58.02	105.97	200.63	10.6	-9.21
Total Liabilities & Equity	168.23	204.37	146	233.33	28.08	6.12
Total Debt	126.95	128.43	22.58	19.87	11.73	11.89
Net Cash (Debt)	-81.1	-55	102.1	205.46	11.22	-9.62
Net Cash Growth	-	-	-50.31%	1731.34%	-	-
Net Cash Per Share	-1.47	-1.02	2.13	9.17	2.87	-2.90
Filing Date Shares Outstanding	55.15	55.15	48.1	47.81	4.47	3.32
Total Common Shares Outstanding	55.15	55.14	48.07	47.79	4.47	3.32
Working Capital	30.52	63.08	115.63	217.3	16.3	0.43
Book Value Per Share	0.48	1.05	2.20	4.20	-14.47	-10.82
Tangible Book Value	26.26	58.02	105.97	200.63	-64.63	-35.92
Tangible Book Value Per Share	0.48	1.05	2.20	4.20	-14.47	-10.82
Machinery	10.44	9.5	7.4	6.02	4.56	3.02
Construction In Progress	-	0.59	0.83	0.05	0.02	-
Leasehold Improvements	1.43	1.29	1.38	1.38	1.38	1.2

Source: S&P Capital IQ. Standard template. Financial Sources.